| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/1992 | US5093324 Thiadiazole antiviral agents |
| 03/03/1992 | US5093323 Antibiotic n-acetylbenanomicin b, and the production and uses thereof |
| 03/03/1992 | US5093318 Immunostimulating guanosine derivatives and their pharmaceutical compositions |
| 03/03/1992 | US5093247 Phenanthridine derivatives, process for the preparation thereof, and compositions containing them |
| 03/03/1992 | US5093165 Use of films composed of plastics having polar molecular groups as primary packaging for β-lactam antibiotics, and plastic bags |
| 03/03/1992 | US5093143 Dietetic nutrient compositions for patients with kidney insufficiency |
| 03/03/1992 | US5093135 Compounds for the induction of in vivo and in vitro production of cytokines |
| 03/03/1992 | US5093133 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| 03/03/1992 | US5093132 Stabilized pharmaceutical composition and its production |
| 03/03/1992 | US5093131 Administering 2-Isopropyl-2,8-Bis/3,4-Dimethoxyphenyl/-6-Methyl-6-Azaoctanenitrile |
| 03/03/1992 | US5093129 Method for treating addiction to a drug of abuse employing an ace inhibitor |
| 03/03/1992 | US5093127 Cyclodextrin Carrier, Antiallergens |
| 03/03/1992 | US5093122 Allium Plant Extract |
| 03/03/1992 | US5093116 Method of treating viral infection utilizing inteferon α and pipyridamole |
| 03/03/1992 | US5093078 Novel polymeric quaternary ammonium trihalides and use of polymeric quaternary ammonium trihalides as microbicides, sanitizers and disinfectants |
| 03/03/1992 | US5093045 Biologically active lipids binding membrane receptors |
| 03/03/1992 | US5093044 Triglyercide nutrient for humans and animals |
| 03/03/1992 | CA1296740C 4-hydroxy-4-(substituted alkenyl)cyclohexanecarboxylic acids |
| 03/03/1992 | CA1296739C Diphosphonic acid derivatives, processes for the preparation thereofand pharmaceutical compositions containing them |
| 03/03/1992 | CA1296736C Substituted propane-phosphonous acid compounds |
| 03/03/1992 | CA1296735C Platinum(ii) complexes of 2,3-dimercapto-2-butene- dinitrilate(2-)-s,s' derivatives and process for their production |
| 03/03/1992 | CA1296734C 2-alkyl-3-benzoylbenzofurans and pharmaceutical compositions containing same |
| 03/03/1992 | CA1296731C 5-phenyl-1,4-dihydropyridines, process for their preparation and their use in medicaments |
| 03/03/1992 | CA1296730C 6,7,8,9-tetrahydropyrido[1,2-a] indole derivatives |
| 03/03/1992 | CA1296728C 1,3,5-trithian derivatives |
| 03/03/1992 | CA1296726C 9-hydroxyalkoxyguanines |
| 03/03/1992 | CA1296724C 4-substituted 10-cyanomethylenepyrrolo [4,3-e]-benzazepines |
| 03/03/1992 | CA1296721C Diacyl derivatives of 4-(trialkylbenzyl)-piperazinyl compounds |
| 03/03/1992 | CA1296718C C.12 modified erythromycin a derivatives |
| 03/03/1992 | CA1296717C Crystalline salts of [3s(z)]-2[[[1-(2-amino- 4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)- 3-azetidinyl]-amino]-2-oxoethylidene]-amino]oxy]acetic acid |
| 03/03/1992 | CA1296716C N-(2-substituted alkyl)-n'-[(imidazole-4-yl) alkyl] guanidine |
| 03/03/1992 | CA1296641C Physiologically active and nutritional composition |
| 03/03/1992 | CA1296640C Special lipid mixture for membrane fluidization |
| 03/03/1992 | CA1296637C Pharmaceutical composition for the treatment of gastrointestinal disorders |
| 03/03/1992 | CA1296636C 2-pyridinol compounds useful as anabolic agents |
| 03/03/1992 | CA1296635C Pharmaceutical composition containing quinoline dicarboxylic acid derivatives |
| 03/03/1992 | CA1296634C Pharmaceutical formulations of ciprofloxacin |
| 03/03/1992 | CA1296633C Controlled release bases for pharmaceuticals |
| 03/03/1992 | CA1296630C Dual phase solvent carrier system |
| 03/01/1992 | WO1992004338A1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 03/01/1992 | WO1992004322A1 Alpha-substituted tryptophane dipeptoid derivatives |
| 03/01/1992 | WO1992004048A2 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 03/01/1992 | WO1992004024A2 Toxic agent protective compounds, compositions and method |
| 03/01/1992 | WO1992004016A1 Pharmaceutical composition of florfenicol |
| 03/01/1992 | CA2089375A1 Inhibition of metastatis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 03/01/1992 | CA2089158A1 Toxic agent protective compounds, compositions and method |
| 03/01/1992 | CA2088996A1 Alpha-substituted tryptophane dipeptoid derivatives |
| 03/01/1992 | CA2050268A1 Hetrazepinoid amides |
| 03/01/1992 | CA2050264A1 Substituted pyrazine and its salts, compositions containing them and their use in medicine |
| 03/01/1992 | CA2050172A1 Preparation for treating renal disease |
| 03/01/1992 | CA2050049A1 Nor-statine and nor-cyclostatine polypeptides in the treatment of ocular hypertension and glaucoma |
| 03/01/1992 | CA2049803A1 Serotonin 5ht1a agonists |
| 03/01/1992 | CA2049490A1 Pyrrolobenzimidazoles, imidazobenzoxazinones and imidazoquinolones, process for their preparation and their use and preparations containing the compounds |
| 03/01/1992 | CA2048309A1 Method and compositions for inhibiting aminoglycoside nephrotoxicity |
| 03/01/1992 | CA2024220A1 Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| 02/28/1992 | CA2049902A1 Method for treating inflammation, ischemia-induced cell damage and muscular distrophy |
| 02/28/1992 | CA2049817A1 Gemfibrozil formulations |
| 02/28/1992 | CA2049642A1 Indolonaphthyridines |
| 02/28/1992 | CA2049481A1 Method of treating inflammatory bowel disease |
| 02/27/1992 | DE4026683A1 Compsn. for treating CNS tumours - contains active cpd. conjugated to saponin, flavone or saccharide, to allow binding to lipid bi-layer of tumour cells |
| 02/27/1992 | DE4026265A1 Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel New phospholipid derivatives of nucleosides, their production and their use as antiviral drug |
| 02/26/1992 | EP0472501A2 Codeinsalt of a substituted carbonacid, process of its preparation, its use and pharmaceutical preparations |
| 02/26/1992 | EP0472449A2 Substituted sulfonamides, processes for their preparation and medicines containing them |
| 02/26/1992 | EP0472434A2 Antisense oligonucleotides complementary to the macromolecular synthesis operon of bacteria, and their uses in diagnosis and therapy |
| 02/26/1992 | EP0472327A1 Composition for eye drops |
| 02/26/1992 | EP0472325A2 Acid addition salts of an optically active alaninanilide compound and pharmaceutical compositions containing the same |
| 02/26/1992 | EP0472306A1 2-(9-fluorenonyl)-carbapenem antibacterial agents |
| 02/26/1992 | EP0472304A2 Pharmaceutical compositions containing therapeutically active organosilane derivatives and process for preparing same |
| 02/26/1992 | EP0472225A2 Hydrated lammelar lipidic phases or liposomes containing tretinoid |
| 02/26/1992 | EP0472181A2 5-Amine substituted adenosine analogs as immunosuppressants |
| 02/26/1992 | EP0472166A1 Tricyclic pyridone derivatives |
| 02/26/1992 | EP0472078A2 Phosphonopyrrolidin- and piperidin-containing statin-type pseudopeptides, their preparation and use against retroviruses |
| 02/26/1992 | EP0472077A2 Phosphonate containing hydroxyethylamin- and norstatin-type pseudopeptides |
| 02/26/1992 | EP0472060A2 Antibiotic c-7 catechol-subtituted cephalosporin compounds, compositions, and use thereof |
| 02/26/1992 | EP0472053A2 Sulfonamide derivatives |
| 02/26/1992 | EP0472033A2 3,5-Diiod-L-thyronin for TSH-suppression and the treatment of goiter |
| 02/26/1992 | EP0472005A1 Antiviral antibiotic BU-4224V |
| 02/26/1992 | EP0471991A2 1-Phenyl substituted 1H,3H-thiazolo[3,4-a]benzimidazoles, process for their preparation, and pharmaceutical compositions containing them |
| 02/26/1992 | EP0471967A1 Chewable tablet containing sucralfate |
| 02/26/1992 | EP0471872A1 Antifungal gel formulations |
| 02/26/1992 | EP0471856A1 15-deoxyprostaglandin derivative |
| 02/26/1992 | EP0471841A1 Sulfonamide derivative and pharmaceutical composition containing the same |
| 02/26/1992 | EP0471820A1 Diastereoisomeric compounds derived from tetrahydrofolic acid, process for their preparation and use in the synthesis of diastereoisomers 6s and 6r of reduced folates |
| 02/26/1992 | EP0471796A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| 02/26/1992 | EP0471750A1 Heterocyclic n-oxide derivatives of substituted benzo 5,6]cycloheptapyridines, compositions and methods of use |
| 02/26/1992 | EP0471718A1 Pharmaceutical composition with a paracetamol base. |
| 02/26/1992 | EP0471707A1 Laser diode pumped solid state laser. |
| 02/26/1992 | EP0471683A1 Bis-(pyrrolidonyl alkylene) biguanides |
| 02/26/1992 | EP0471668A1 Device for the transdermal delivery of nicotine |
| 02/26/1992 | EP0211037B1 METHOD OF PRODUCING HIGH MOLECULAR WEIGHT SODIUM HYALURONATE BY FERMENTATION OF $i(STREPTOCOCCUS) |
| 02/26/1992 | CN1058967A Antipsychotic fused-ring pyridinylpiperazine derivatives |
| 02/26/1992 | CN1058965A Process for preparing quinoline derivatives |
| 02/26/1992 | CN1058963A Diphenylmethyl piperazine derivatives |
| 02/26/1992 | CN1058962A 6-substituted-hexahydrobenz(cd)indoles |
| 02/26/1992 | CN1058961A 6-substituted-tetrahydrobenz(cd)indoles |
| 02/26/1992 | CN1058959A Oligomers, their uses and formulations |
| 02/26/1992 | CN1058958A Hiv-inhibiting benzeneacetamide derivatives |
| 02/26/1992 | CN1058903A Toothpaste without brushing |
| 02/26/1992 | CN1015627B Aryl piperazinyl-alkylene phenyl heterocyclic compounds |
| 02/26/1992 | CN1015622B Hydrocinnamic acid derivatives |